39 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... Tuberculosis #Drugs #Medications ... #management #pharmacology
Medications Used in Hypertensive Emergencies
Vasodilators: Hydralazine, Nitroglycerin, Sodium nitroprusside 
Calcium Channel Blockers: Clevidipine, Nicardipine
ß-Blockers: Esmolol, Labetalol,
Medications Used ... Labetalol, Metoprolol ACE ... #Hypertension #Medications ... #Management #Treatment ... #Pharmacology #
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Therapy for AL Amyloidosis 2019 
 - Antibodies (Plasma cells) 
 - Proteasome Inhibitors 
 -
Therapy for AL Amyloidosis ... ALAmyloidosis #Therapy #Medications ... #Therapies #Pharmacology ... #Management #Classes
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HumanPapillomavirus #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... Prevention #Treatment #opportunistic ... infections #HIVAIDS #management ... #pharmacology # ... pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... candida #mucosal #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology